Chronic Kidney Disease
Part of NephTimes
Advertisement
The American Heart Association has launched a 4-year plan to improve awareness and treatment of CKM syndrome.
Could a lifestyle intervention intended for overweight or obese diabetes patients improve kidney function?
The FDA approved Velphoro (sucroferric oxyhydroxide) for hyperphosphatemia in patients with CKD as young as age 9.
Dialysis Patient Citizens has launched a first-in-the-nation kidney disease training curriculum for community health workers.
Researchers studied the efficacy of a community pharmacist-led nutritional intervention for outpatients with CKD.
The Kidney Foundation of Canada is seeking feedback through a survey to inform development of a national CKD framework.
Akebia Therapeutics has ended its license agreement with CSL Vifor for Vafseo and announced WAC pricing for the anemia drug.
Novo Nordisk stopped the phase 3 CLARION-CKD trial of ocedurenone due to disappointing results.
Iron replacement with ferric citrate hydrate decreased cFGF23 and normalized platelet count with anemia regardless of CKD.
Black adults have higher hazards of progression to kidney failure and lower hazards of competing risk of death.
Kidney care providers can play a role in depression screening and help improve outcomes for patients with CKD.
Humana issued an issue brief focusing on the benefits of value-based care in nephrology.
The International Society of Nephrology and WHO brought stakeholders together to discuss global disparities in kidney care.
Long-term exposure to ozone is associated with an increased risk of ESRD and mortality in chronic kidney disease.
The Congressional Kidney Caucus and kidney organizations are calling for federal screening recommendations for CKD.
Whether ULT should be used in CKD patients with asymptomatic hyperuricemia to prevent the progression of CKD is uncertain.
Recognizing and managing concurrent gout and CKD is important for improving outcomes but can be difficult.
There are few data on whether finerenone-induced change in UACR mediates cardiovascular and kidney failure outcomes.
AI technology to detect elevated CKD risk in people with diabetes received Breakthrough Device designation from the FDA.
How does sodium bicarbonate affect bone health markers in patients with chronic kidney disease (CKD)?
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2024 Mashup Media, LLC. All rights reserved.